About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

S&P Spin-Off Invesco ETF (NY: CSD )

74.93 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EDT, Aug 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 74.93
Bid (Size) 70.59 (2)
Ask (Size) 79.12 (2)
Prev. Close 74.93
Today's Range 74.93 - 74.93
52wk Range 52.14 - 76.18
Shares Outstanding 8,000
Dividend Yield 0.60%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GXO Logistics Q2: Revenue Gains Offset By Profit Margin Squeeze
GXO Logistics beats revenue consensus with $2.85B in Q2. Organic revenue rose 2%, new business wins add $270M. FY24 outlook reaffirmed. 
Via Benzinga
GE HealthCare Taps AWS for Groundbreaking AI Medical Solutions: Details
GEHC and AWS partner to advance healthcare through specialized foundation models and generative AI apps, using AWS' cloud and AI services. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence

Performance

YTD
+17.65%
+17.65%
1 Month
+1.10%
+1.10%
3 Month
+4.51%
+4.51%
6 Month
+10.75%
+10.75%
1 Year
+30.65%
+30.65%

More News

Read More
What's Going On With GE Vernova Shares Today?
Via Benzinga
GXO Logistics Deploys Robotics Solution For Sporting Goods Retailer In France
Via Benzinga
Tap Into Trends: 3 Thematic ETFs to Capture the Market’s Pulse
Via InvestorPlace
Topics ETFs
Why Carrier Global Shares Are Surging Today
Via Benzinga
Why Apartment Income REIT Shares Are Rocketing Today
Via Benzinga
Radiopharmaceuticals Startup RayzeBio Seeks Public Debut After Raising $400M From Investors
Via Benzinga
Healthcare Software Firm Waystar Goes IPO Way With Potential $8B Valuation
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Second Time Charm: Sagimet Biosciences Seeks Public Debut With $75M IPO
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.